Common Contracts
4 similar null contracts by Regeneron Pharmaceuticals Inc, Regeneron Pharmaceuticals, Inc.
Third Amended and Restated Guaranty dated as of March 27, 2023 and effective as of the Restatement Date made by Regeneron Pharmaceuticals, Inc., as Parent Guarantor, and the Subsidiary Guarantors party hereto from time to timeRegeneron Pharmaceuticals, Inc. • March 29th, 2023 • Pharmaceutical preparations • New York
This Third Amended and Restated Guaranty (as amended, restated, supplemented or otherwise modified from time to time, this “Guaranty”), dated as of March 27, 2023, and effective as of the Restatement Date, is made by (i) Regeneron Pharmaceuticals, Inc., a New York corporation (the “Parent Guarantor”), (ii) each of the undersigned Subsidiaries (as hereinafter defined) of the Parent Guarantor (the “Initial Subsidiary Guarantors” and together with the Parent Guarantor, the “Initial Guarantors”) and (iii) any additional Subsidiaries of the Parent Guarantor which become parties to this Guaranty by executing a supplement hereto in the form attached as Annex I (collectively with the Initial Subsidiary Guarantors, the “Subsidiary Guarantors” and together with the Parent Guarantor, the “Guarantors”) in favor of (a) each Participant (as hereinafter defined) and (b) Bank of America, N.A., not in its individual capacity, except as expressly stated therein, but solely as Administrative Agent (toget
Second Amended and Restated Guaranty dated as of March 2, 2022 and effective as of the Restatement Date made by Regeneron Pharmaceuticals, Inc., as Parent Guarantor, and the Subsidiary Guarantors party hereto from time to timeRegeneron Pharmaceuticals, Inc. • March 8th, 2022 • Pharmaceutical preparations • New York
This Second Amended and Restated Guaranty (as amended, restated, supplemented or otherwise modified from time to time, this “Guaranty”), dated as of March 2, 2022, and effective as of the Restatement Date, is made by (i) Regeneron Pharmaceuticals, Inc., a New York corporation (the “Parent Guarantor”), (ii) each of the undersigned Subsidiaries (as hereinafter defined) of the Parent Guarantor (the “Initial Subsidiary Guarantors” and together with Parent Guarantor, the “Initial Guarantors”) and (iii) any additional Subsidiaries of the Parent Guarantor which become parties to this Guaranty by executing a supplement hereto in the form attached as Annex I (collectively with the Initial Subsidiary Guarantors, the “Subsidiary Guarantors” and together with Parent Guarantor, the “Guarantors”) in favor of (a) each Participant (as hereinafter defined) and (b) Bank of America, N.A., not in its individual capacity, except as expressly stated therein, but solely as Administrative Agent (together with
Amended and Restated Guaranty dated as of May 2, 2019Regeneron Pharmaceuticals Inc • May 3rd, 2019 • Pharmaceutical preparations • New York
This Amended and restated guaranty (as amended, restated, supplemented or otherwise modified from time to time, this “Guaranty”), dated as of May 2, 2019, is made by (i) Regeneron Pharmaceuticals, Inc., a New York corporation (the “Parent Guarantor”), (ii) each of the undersigned Subsidiaries (as hereinafter defined) of the Parent Guarantor (the “Initial Subsidiary Guarantors” and together with Parent Guarantor, the “Initial Guarantors”) and (iii) any additional Subsidiaries of the Parent Guarantor which become parties to this Guaranty by executing a supplement hereto in the form attached as Annex I (collectively with the Initial Subsidiary Guarantors, the “Subsidiary Guarantors” and together with Parent Guarantor, the “Guarantors”) in favor of (a) each Participant (as hereinafter defined) and (b) Bank of America, N.A., not in its individual capacity, except as expressly stated therein, but solely as Administrative Agent (together with its successors and permitted assigns, in its capac
GUARANTY dated as of March 3, 2017 made by REGENERON PHARMACEUTICALS, INC., as Parent Guarantor, and The Subsidiary Guarantors party hereto from time to timeRegeneron Pharmaceuticals Inc • March 9th, 2017 • Pharmaceutical preparations • New York
THIS GUARANTY (as amended, restated, supplemented or otherwise modified from time to time, this “Guaranty”), dated as of March 3, 2017, is made by (i) REGENERON PHARMACEUTICALS, INC., a New York corporation (the “Parent Guarantor”), (ii) each of the undersigned Subsidiaries (as hereinafter defined) of the Parent Guarantor (the “Initial Subsidiary Guarantors” and together with Parent Guarantor, the “Initial Guarantors”) and (iii) any additional Subsidiaries of the Parent Guarantor which become parties to this Guaranty by executing a supplement hereto in the form attached as Annex I (collectively with the Initial Subsidiary Guarantors, the “Subsidiary Guarantors” and together with Parent Guarantor, the “Guarantors”) in favor of (a) each Participant (as hereinafter defined) and (b) the Administrative Agent (as hereinafter defined), for the benefit of itself and the other Beneficiaries (as hereinafter defined).
